Higher risk, lower reimbursement: medicare payment paradox in cranial neurosurgery. [PDF]
Schneider D +7 more
europepmc +1 more source
Twelve‐Month Real‐World Outcomes of Faricimab for Treatment‐Naive Neovascular AMD in Australia
ABSTRACT Background To provide insights into the effectiveness and safety of faricimab for treatment‐naïve eyes with neovascular age‐related macular degeneration (nAMD). Methods A retrospective cohort study using a prospectively‐designed registry. Treatment‐naïve eyes with nAMD in Australia starting treatment with faricimab between Jan 2023–Sep 2024 ...
Mark Gillies +8 more
wiley +1 more source
Prescriptions for Excellence in Health Care Fall 2012 Download Full Issue #17 [PDF]
core +1 more source
ABSTRACT Family members may be impacted by complex care requirements around childhood disability, although little research provides guidance on the changing needs of families under unexpected circumstances. This study investigated parents' experiences and reports of the impact of COVID‐19 lockdowns in Australia on family members in families raising a ...
Helen Bourke‐Taylor +6 more
wiley +1 more source
Implementation and costs of a food insecurity resource navigation program for primary care patients with diabetes and hypertension in South Carolina. [PDF]
Gupta D +7 more
europepmc +1 more source
Performance of Novel Inflammatory Bowel Disease-Specific Models for Risk Adjustment. [PDF]
Moran KM +4 more
europepmc +1 more source
Comparison of Recent Trends in Medicare Utilization and Reimbursement for Anterior Cervical Spine Discectomy and Fusion as Compared to Cervical Disc Arthroplasty. [PDF]
Davidson JC +8 more
europepmc +1 more source
Trends in Anti-Vascular Endothelial Growth Factor Injections Among Medicare Part B Beneficiaries in 2013-2021 and the Step Therapy Era. [PDF]
Bryan JM, Sheth N, Heiferman MJ.
europepmc +1 more source
Characterizing Medicare Medication Therapy Management program enrollees with central nervous system-active polypharmacy. [PDF]
Hung A +12 more
europepmc +1 more source

